Minerva Biotechnologies, Kyoto University deal

The university’s technology transfer arm, iPS Academia Japan Inc., granted Minerva non-exclusive, worldwide rights to develop and commercialize iPS Academia’s induced pluripotent stem (iPS) cell pate...